Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,800 | 107,700 | 87,700 | 127,700 | 118,500 |
| Receivables | 103,800 | 132,800 | 142,800 | 167,900 | 131,200 |
| Inventories | 148,000 | 138,800 | 163,200 | 132,300 | 159,300 |
| Other current assets | 0 | 0 | 64,500 | 182,300 | 0 |
| TOTAL | $355,400 | $393,400 | $487,000 | $624,100 | $427,600 |
| Non-Current Assets | |||||
| PPE Net | 113,400 | 110,700 | 117,200 | 118,600 | 168,100 |
| Intangibles | 512,700 | 567,900 | 1,035,600 | 994,500 | 942,800 |
| Other Non-Current Assets | 92,200 | 82,200 | 52,600 | 49,700 | 65,100 |
| TOTAL | $718,300 | $760,800 | $1,205,400 | $1,162,800 | $1,176,000 |
| Total Assets | $1,073,700 | $1,154,200 | $1,692,400 | $1,786,900 | $1,603,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,200 | 9,400 | 8,600 | 6,200 | 0 |
| Accounts payable and accrued liabilities | 55,500 | 54,300 | 56,300 | 67,900 | 56,400 |
| Accrued Expenses | 91,300 | 91,300 | 93,200 | 97,800 | 68,100 |
| Other current liabilities | N/A | N/A | 63,700 | 7,100 | N/A |
| TOTAL | $165,200 | $165,900 | $234,600 | $191,000 | $139,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 90,300 | 125,300 | 159,400 | 226,300 | 130,000 |
| Other Non-Current Liabilities | 33,900 | 29,000 | 38,300 | 53,000 | 51,900 |
| TOTAL | $130,300 | $159,800 | $221,500 | $304,700 | $193,800 |
| Total Liabilities | $295,500 | $325,700 | $456,100 | $495,700 | $333,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,503 | 46,003 | 46,203 | 46,599 | 47,318 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -779,900 | -707,000 | -314,900 | -253,100 | -303,600 |
| Other shareholders' equity | -32,300 | -44,600 | -26,900 | -35,600 | -34,100 |
| TOTAL | $778,200 | $828,500 | $1,236,300 | $1,291,200 | $1,270,600 |
| Total Liabilities And Equity | $1,073,700 | $1,154,200 | $1,692,400 | $1,786,900 | $1,603,600 |